| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68094-044-61 | 68094-044 | HUMAN PRESCRIPTION DRUG | Calcium Acetate | Calcium Acetate | CAPSULE | ORAL | 20220506 | N/A | ANDA | ANDA091312 | Precision Dose, Inc. | CALCIUM ACETATE | 667 mg/1 | 10 BLISTER PACK in 1 CARTON (68094-044-61) / 10 CAPSULE in 1 BLISTER PACK (68094-044-59) |
| 62135-191-22 | 62135-191 | HUMAN PRESCRIPTION DRUG | Calcium Acetate | Calcium Acetate | CAPSULE | ORAL | 20180629 | N/A | ANDA | ANDA091312 | Chartwell RX, LLC. | CALCIUM ACETATE | 667 mg/1 | 200 CAPSULE in 1 BOTTLE (62135-191-22) |
| 62135-191-30 | 62135-191 | HUMAN PRESCRIPTION DRUG | Calcium Acetate | Calcium Acetate | CAPSULE | ORAL | 20180629 | N/A | ANDA | ANDA091312 | Chartwell RX, LLC. | CALCIUM ACETATE | 667 mg/1 | 30 CAPSULE in 1 BOTTLE (62135-191-30) |
| 62135-191-73 | 62135-191 | HUMAN PRESCRIPTION DRUG | Calcium Acetate | Calcium Acetate | CAPSULE | ORAL | 20180629 | N/A | ANDA | ANDA091312 | Chartwell RX, LLC. | CALCIUM ACETATE | 667 mg/1 | 750 CAPSULE in 1 BOTTLE (62135-191-73) |